Are We Ready for Genetic Testing for Primary Open-angle Glaucoma?

Overview

Journal Eye (Lond)

Specialty Ophthalmology

Date 2018 Jan 31

PMID 29379103

Citations 15

Authors

Anthony P Khawaja

Ananth C Viswanathan

Affiliations

Soon will be listed here.

Abstract

Following a dramatic reduction in the cost of genotyping technology in recent years, there have been significant advances in the understanding of the genetic basis of glaucoma. Glaucoma patients represent around a quarter of all outpatient activity in the UK hospital eye service and are a huge burden for the National Health Service. A potential benefit of genetic testing is personalised glaucoma management, allowing direction of our limited healthcare resources to the glaucoma patients who most need it. Our review aims to summarise recent discoveries in the field of glaucoma genetics and to discuss their potential clinical utility. While genome-wide association studies have now identified over ten genes associated with primary open-angle glaucoma (POAG), individually, variants in these genes are not predictive of POAG in populations. There are data suggesting some of these POAG variants are associated with conversion from ocular hypertension to POAG and visual field progression among POAG patients. However, these studies have not been replicated yet and such genetic testing is not currently justified in clinical care. In contrast, genetic testing for inherited early-onset disease in relatives of POAG patients with a known genetic mutation is of clear benefit; this can support either regular review to commence early treatment when the disease develops, or discharge from ophthalmology services of relatives who do not carry the mutation. Genetic testing for POAG at a population level is not currently justified.

Citing Articles

Li K, Tolman N, V Segre A, Stuart K, Stuart K, Zeleznik O bioRxiv. 2025; .

PMID: 39896457 PMC: 11785086. DOI: 10.1101/2025.01.18.633745.

Early diagnostics and interventional glaucoma.

De Francesco T, Bacharach J, Smith O, Shah M Ther Adv Ophthalmol. 2024; 16:25158414241287431.

PMID: 39421852 PMC: 11483761. DOI: 10.1177/25158414241287431.

Genetic Risk Assessment of Degenerative Eye Disease (GRADE): study protocol of a prospective assessment of polygenic risk scores to predict diagnosis of glaucoma and age-related macular degeneration.

Hollitt G, Qassim A, Thomson D, Schmidt J, Nguyen T, Landers J BMC Ophthalmol. 2023; 23(1):431.

PMID: 37875865 PMC: 10594830. DOI: 10.1186/s12886-023-03143-5.

Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.

Moreira Vasconcelos C, Ribas V, Petrs-Silva H Cells. 2023; 12(17).

PMID: 37681887 PMC: 10486375. DOI: 10.3390/cells12172155.

Deep Ocular Phenotyping Across Primary Open-Angle Glaucoma Genetic Burden.

Sekimitsu S, Xiang D, Smith S, Curran K, Elze T, Friedman D JAMA Ophthalmol. 2023; 141(9):891-899.

PMID: 37589995 PMC: 10436188. DOI: 10.1001/jamaophthalmol.2023.3645.

References

Souzeau E, Glading J, Ridge B, Wechsler D, Chehade M, Dubowsky A . Predictive genetic testing in minors for Myocilin juvenile onset open angle glaucoma. Clin Genet. 2015; 88(6):584-8. DOI: 10.1111/cge.12558. View

Fingert J, Robin A, Stone J, Roos B, Davis L, Scheetz T . Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. Hum Mol Genet. 2011; 20(12):2482-94. PMC: 3098731. DOI: 10.1093/hmg/ddr123. View

Aung T, Ozaki M, Mizoguchi T, Allingham R, Li Z, Haripriya A . A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome. Nat Genet. 2015; 47(4):387-92. PMC: 4605818. DOI: 10.1038/ng.3226. View

McCarty C, Berg R, Patchett R, Wilke R, Burmester J . Lack of association between polymorphisms in the prostaglandin F2α receptor and solute carrier organic anion transporter family 2A1 genes and intraocular pressure response to prostaglandin analogs. Ophthalmic Genet. 2011; 33(2):74-6. PMC: 3832133. DOI: 10.3109/13816810.2011.628357. View

Whirl-Carrillo M, McDonagh E, Hebert J, Gong L, Sangkuhl K, Thorn C . Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2012; 92(4):414-7. PMC: 3660037. DOI: 10.1038/clpt.2012.96. View

Vithana E, Khor C, Qiao C, Nongpiur M, George R, Chen L . Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma. Nat Genet. 2012; 44(10):1142-1146. PMC: 4333205. DOI: 10.1038/ng.2390. View

Burdon K, Macgregor S, Hewitt A, Sharma S, Chidlow G, Mills R . Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet. 2011; 43(6):574-8. DOI: 10.1038/ng.824. View

Scheetz T, Faga B, Ortega L, Roos B, Gordon M, Kass M . Glaucoma Risk Alleles in the Ocular Hypertension Treatment Study. Ophthalmology. 2016; 123(12):2527-2536. PMC: 5121091. DOI: 10.1016/j.ophtha.2016.08.036. View

Trikha S, Saffari E, Nongpiur M, Baskaran M, Ho H, Li Z . A Genetic Variant in TGFBR3-CDC7 Is Associated with Visual Field Progression in Primary Open-Angle Glaucoma Patients from Singapore. Ophthalmology. 2015; 122(12):2416-22. DOI: 10.1016/j.ophtha.2015.08.016. View

10.

Alward W, Kwon Y, Kawase K, Craig J, Hayreh S, Johnson A . Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma. Am J Ophthalmol. 2003; 136(5):904-10. DOI: 10.1016/s0002-9394(03)00577-4. View

11.

Chen Y, Lin Y, Vithana E, Jia L, Zuo X, Wong T . Common variants near ABCA1 and in PMM2 are associated with primary open-angle glaucoma. Nat Genet. 2014; 46(10):1115-9. DOI: 10.1038/ng.3078. View

12.

Khor C, Do T, Jia H, Nakano M, George R, Abu-Amero K . Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. Nat Genet. 2016; 48(5):556-62. DOI: 10.1038/ng.3540. View

13.

Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M . Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002; 295(5557):1077-9. DOI: 10.1126/science.1066901. View

14.

Souzeau E, Burdon K, Dubowsky A, Grist S, Usher B, Fitzgerald J . Higher prevalence of myocilin mutations in advanced glaucoma in comparison with less advanced disease in an Australasian disease registry. Ophthalmology. 2013; 120(6):1135-43. DOI: 10.1016/j.ophtha.2012.11.029. View

15.

Wolfs R, Klaver C, Ramrattan R, van Duijn C, Hofman A, de Jong P . Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol. 1998; 116(12):1640-5. DOI: 10.1001/archopht.116.12.1640. View

16.

Gharahkhani P, Burdon K, Fogarty R, Sharma S, Hewitt A, Martin S . Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. Nat Genet. 2014; 46(10):1120-1125. PMC: 4177327. DOI: 10.1038/ng.3079. View

17.

Tham Y, Li X, Wong T, Quigley H, Aung T, Cheng C . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121(11):2081-90. DOI: 10.1016/j.ophtha.2014.05.013. View

18.

Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E, Liebmann J . Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet. 2005; 14(6):725-33. DOI: 10.1093/hmg/ddi068. View

19.

Springelkamp H, Iglesias A, Mishra A, Hohn R, Wojciechowski R, Khawaja A . New insights into the genetics of primary open-angle glaucoma based on meta-analyses of intraocular pressure and optic disc characteristics. Hum Mol Genet. 2017; 26(2):438-453. PMC: 5968632. DOI: 10.1093/hmg/ddw399. View

20.

Ludwig K, Neuner J, Butler A, Geurts J, Kong A . Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg. 2016; 212(4):660-669. DOI: 10.1016/j.amjsurg.2016.06.010. View